Is Beta-Amyloid Accumulation a Cause or Consequence of Alzheimer's Disease?

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Alzheimer's, Parkinsonism and dementia

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 28815226PMCID PMC5555607
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The blood-brain barrier in Alzheimer's disease

  2017cited by this paper
• miR-124 Regulates the Expression of BACE1 in the Hippocampus Under Chronic Cerebral Hypoperfusion

  2017cited by this paper
• Molecular mechanisms and cell signaling of 20-hydroxyeicosatetraenoic acid in vascular pathophysiology.

  2016cited by this paper
• A murine model of inflammation-induced cerebral microbleeds

  2016cited by this paper
• Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer’s disease

  2016cited by this paper
• Reduced Efficacy of Anti-Aβ Immunotherapy in a Mouse Model of Amyloid Deposition and Vascular Cognitive Impairment Comorbidity

  2016influential reference
• The amyloid-beta forming tripeptide cleavage mechanism of γ-secretase

  2016cited by this paper
• Neuroinflammatory mechanisms of hypertension: potential therapeutic implications

  2016cited by this paper
• Amyloid β Protein Aggravates Neuronal Senescence and Cognitive Deficits in 5XFAD Mouse Model of Alzheimer's Disease

  2016cited by this paper
• Hypertension and the Brain: A Risk Factor for More Than Heart Disease

  2016cited by this paper
• Alzheimer's disease: Attack on amyloid-β protein

  2016cited by this paper
• Cerebrovascular disease in ageing and Alzheimer’s disease

  2015cited by this paper
• Ischemic conditions and ß-secretase activation: The impact of membrane cholesterol enrichment as triggering factor in rat brain endothelial cells.

  2015cited by this paper
• Impaired myogenic response and autoregulation of cerebral blood flow is rescued in CYP4A1 transgenic Dahl salt-sensitive rat.

  2015cited by this paper
• Zinc-Finger Nuclease Knockout of Dual-Specificity Protein Phosphatase-5 Enhances the Myogenic Response and Autoregulation of Cerebral Blood Flow in FHH.1BN Rats

  2014cited by this paper
• The overlap between vascular disease and Alzheimer’s disease - lessons from pathology

  2014cited by this paper
• Interleukin-1β Induces Blood–Brain Barrier Disruption by Downregulating Sonic Hedgehog in Astrocytes

  2014cited by this paper
• Hypertension and dementia.

  2014cited by this paper
• A phase 3 trial of semagacestat for treatment of Alzheimer's disease.

  2013cited by this paper
• Human LilrB2 Is a β-Amyloid Receptor and Its Murine Homolog PirB Regulates Synaptic Plasticity in an Alzheimer’s Model

  2013cited by this paper
• Semagacestat for treatment of Alzheimer's disease.

  2013cited by this paper
• Semagacestat for treatment of Alzheimer's disease.

  2013cited by this paper
• Monetary costs of dementia in the United States.

  2013cited by this paper
• Monetary costs of dementia in the United States.

  2013cited by this paper
• Amyloid-β1–42 oligomer accelerates senescence in adult hippocampal neural stem/progenitor cells via formylpeptide receptor 2

  2013cited by this paper
• Pathology and pathogenesis of vascular cognitive impairment—a critical update

  2013cited by this paper
• Hypertension: A Harbinger of Stroke and Dementia

  2013cited by this paper
• Astrocyte Senescence as a Component of Alzheimer’s Disease

  2012cited by this paper
• Alzheimer's Disease, Cerebrovascular Disease, and the β-amyloid Cascade

  2012cited by this paper
• Safety and tolerability of the γ-secretase inhibitor avagacestat in a phase 2 study of mild to moderate Alzheimer disease.

  2012cited by this paper
• Alzheimer's disease.

  2012cited by this paper
• A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease.

  2012cited by this paper
• Amyloid β (Aβ) and phospho-tau (p-tau) as diagnostic biomarkers in Alzheimer's disease

  2011cited by this paper
• Alzheimer's disease.

  2011cited by this paper
• Pressure-induced myogenic tone and role of 20-HETE in mediating autoregulation of cerebral blood flow.

  2011cited by this paper
• Pathological role of hypoxia in Alzheimer's disease.

  2010influential reference
• Amyloid β accelerates phosphorylation of tau and neurofibrillary tangle formation in an amyloid precursor protein and tau double‐transgenic mouse model

  2010cited by this paper
• Advances in vascular cognitive impairment.

  2010cited by this paper
• Advances in vascular cognitive impairment.

  2009cited by this paper
• Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease

  2009influential reference
• A γ‐secretase inhibitor decreases amyloid‐β production in the central nervous system

  2009cited by this paper
• SRF and myocardin regulate LRP-mediated amyloid-β clearance in brain vascular cells

  2009influential reference
• Alzheimer's Mechanisms in Ischemic Brain Degeneration

  2009influential reference
• Phase 2 safety trial targeting amyloid beta production with a gamma-secretase inhibitor in Alzheimer disease.

  2008cited by this paper
• IL-4-Induced Selective Clearance of Oligomeric β-Amyloid Peptide1–42 by Rat Primary Type 2 Microglia1

  2008cited by this paper
• Safety, tolerability, and effects on plasma and cerebrospinal fluid amyloid-beta after inhibition of gamma-secretase.

  2007cited by this paper
• Stable isotope labeling tandem mass spectrometry (SILT) to quantify protein production and clearance rates

  2007cited by this paper
• Summary health statistics for U.S. adults: National Health Interview Survey, 2005.

  2006cited by this paper
• Hypertensive cerebral small vessel disease and stroke.

  2006cited by this paper
• Cathepsin D-mediated proteolysis of apolipoprotein E: possible role in Alzheimer's disease.

  2006cited by this paper
• Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation

  2006cited by this paper
• RAGE, LRP-1, and amyloid-beta protein in Alzheimer’s disease

  2006cited by this paper
• Effects of a gamma-secretase inhibitor in a randomized study of patients with Alzheimer disease.

  2006cited by this paper
• Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing

  2006cited by this paper
• RAGE (Yin) Versus LRP (Yang) Balance Regulates Alzheimer Amyloid &bgr;-Peptide Clearance Through Transport Across the Blood–Brain Barrier

  2004cited by this paper
• Neurovascular regulation in the normal brain and in Alzheimer's disease

  2004cited by this paper
• Cdk5 deregulation in the pathogenesis of Alzheimer's disease.

  2004cited by this paper
• Amyloid‐induced neurofibrillary tangle formation in Alzheimer's disease: insight from transgenic mouse and tissue‐culture models

  2004cited by this paper
• Summary health statistics for U.S. children: National Health Interview Survey, 1999.

  2003cited by this paper
• Vascular basis of Alzheimer's pathogenesis.

  2002cited by this paper
• Cerebral microvascular pathology in aging and Alzheimer's disease.

  2001cited by this paper
• Clearance of amyloid beta-peptide from brain: transport or metabolism?

  2000cited by this paper
• Genes and mechanisms involved in beta-amyloid generation and Alzheimer's disease.

  1999cited by this paper
• Genes and mechanisms involved in β-amyloid generation and Alzheimer’s disease

  1999cited by this paper
• Inflammation, A beta deposition, and neurofibrillary tangle formation as correlates of Alzheimer's disease neurodegeneration.

  1996cited by this paper
• Cerebral circulation: humoral regulation and effects of chronic hypertension.

  1990cited by this paper
• Cerebral autoregulation.

  1990cited by this paper
• Cerebral autoregulation.

  1984cited by this paper

• Increased CD33 levels tune activation and function of induced human microglial cells through inhibition of the TREM2 pathway

  2026influential citation
• Alone in the Mind: Review of Research Examining the Link Between Loneliness and Dementia

  2025cites this paper
• Inhibition of soluble epoxide hydrolase ameliorates cerebral blood flow autoregulation and cognition in alzheimer's disease and diabetes-related dementia rat models

  2025cites this paper
• Ceramides may Play a Central Role in the Pathogenesis of Alzheimer’s Disease: a Review of Evidence and Horizons for Discovery

  2025cites this paper
• Sex Differences in Risk Factors among Alzheimer's Dementia Patients with Metabolic Encephalopathy

  2025cites this paper
• Japanese participant data from three gantenerumab trials in early Alzheimer's disease

  2025cites this paper
• Inhibition of Soluble Epoxide Hydrolase Ameliorates Cerebral Blood Flow Autoregulation and Cognition in Alzheimer’s Disease and Diabetes-Related Dementia Rat Models

  2024cites this paper
• Anthocyanin-Rich Fraction of Black Rice Bran Extract Protects against Amyloid β-Induced Oxidative Stress, Endoplasmic Reticulum Stress, and Neuronal Apoptosis in SK-N-SH Cells

  2024cites this paper
• The duality of amyloid-β: its role in normal and Alzheimer’s disease states

  2024cites this paper
• Aβ-mediated synaptic glutamate dynamics and calcium dynamics in astrocytes associated with Alzheimer’s disease

  2024cites this paper
• Impact of multiple infections on risk of incident dementia according to subjective cognitive decline status: a nationwide population-based cohort study

  2024cites this paper
• Impact of knockout of dual-specificity protein phosphatase 5 on structural and mechanical properties of rat middle cerebral arteries: implications for vascular aging

  2024cites this paper
• Image-guided subject-specific modeling of glymphatic transport and amyloid deposition.

  2023cites this paper
• Cyclophilin D in Mitochondrial Dysfunction: A Key Player in Neurodegeneration?

  2023cites this paper
• Amyloid Fibrils of Pisum sativum L. Vicilin Inhibit Pathological Aggregation of Mammalian Proteins

  2023cites this paper
• Amyloid fibrils degradation: the pathway to recovery or aggravation of the disease?

  2023cites this paper
• Enhanced Cerebral Hemodynamics and Cognitive Function Via Knockout of Dual-Specificity Protein Phosphatase 5

  2023influential citation
• Synthetic receptors in medicine.

  2023cites this paper
• Systolic Blood Pressure Is Associated with Increased Brain Amyloid Load in Mild Cognitively Impaired Participants: Alzheimer’s Disease Neuroimaging Initiatives Study

  2023cites this paper
• Low-Dose Radiation Therapy (LDRT) against Cancer and Inflammatory or Degenerative Diseases: Three Parallel Stories with a Common Molecular Mechanism Involving the Nucleoshuttling of the ATM Protein?

  2023cites this paper
• Role of Dusp5 KO on Vascular Properties of Middle Cerebral Artery in Rats

  2023cites this paper
• Potential Use of the Cholesterol Transfer Inhibitor U18666A as a Potent Research Tool for the Study of Cholesterol Mechanisms in Neurodegenerative Disorders

  2023cites this paper
• Unravelling the Threads: A Brief Insight into Vascular Dementia

  2023cites this paper
• Delivery of the Brainshuttle™ amyloid-beta antibody fusion trontinemab to non-human primate brain and projected efficacious dose regimens in humans

  2023cites this paper
• Impact of impaired cerebral blood flow autoregulation on cognitive impairment

  2022cites this paper
• Evaluation of cognitive function in the Dog Aging Project: associations with baseline canine characteristics

  2022cites this paper
• Bedeutung der multimodalen Bildgebung bei Demenz

  2022cites this paper
• New Evidence on a Distinction between Aβ40 and Aβ42 Amyloids: Thioflavin T Binding Modes, Clustering Tendency, Degradation Resistance, and Cross-Seeding

  2022cites this paper
• From 1901 to 2022, how far are we from truly understanding the pathogenesis of age-related dementia?

  2022cites this paper
• Multi‐Omics‐Based Autophagy‐Related Untypical Subtypes in Patients with Cerebral Amyloid Pathology

  2022cites this paper
• BACE1 Inhibitors for Alzheimer’s Disease: The Past, Present and Any Future?

  2022cites this paper
• Longitudinal characterization of cerebral hemodynamics in the TgF344-AD rat model of Alzheimer’s disease

  2022influential citation
• Natural Marine and Terrestrial Compounds as Modulators of Matrix Metalloproteinases-2 (MMP-2) and MMP-9 in Alzheimer’s Disease

  2021cites this paper
• Luseogliflozin, a sodium-glucose co-transporter 2 inhibitor, reverses cerebrovascular dysfunction and cognitive impairments in 18-month-old diabetic animals.

  2021cites this paper
• Capillary Stalling: A Mechanism of Decreased Cerebral Blood Flow in AD/ADRD

  2021cites this paper
• Diabetes mellitus e hipertensión arterial en la progresión a deterioro cognitivo leve y demencia: una revisión de la literatura

  2021cites this paper
• Three ‐(pyridin‐2‐yl)‐2‐(pyridin‐2‐ylimino)thiazolidin‐4‐one as a novel inhibitor of cerebral MAO‐B activity with antioxidant properties and low toxicity potential

  2021cites this paper
• Nanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer’s disease: from current to future challenges

  2021cites this paper
• Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.

  2021cites this paper
• Mechanistic Modeling of Soluble Aβ Dynamics and Target Engagement in the Brain by Anti-Aβ mAbs in Alzheimer's Disease.

  2020cites this paper
• Thirty-Six-Month Amyloid Positron Emission Tomography Results Show Continued Reduction in Amyloid Burden with Subcutaneous Gantenerumab

  2020cites this paper
• Mitochondrial protein import dysfunction: mitochondrial disease, neurodegenerative disease and cancer

  2020cites this paper
• 5-N-ethyl Carboxamidoadenosine Stimulates Adenosine-2b Receptor-Mediated Mitogen-Activated Protein Kinase Pathway to Improve Brain Mitochondrial Function in Amyloid Beta-Induced Cognitive Deficit Mice

  2020cites this paper
• Accelerated cerebral vascular injury in diabetes is associated with vascular smooth muscle cell dysfunction

  2020cites this paper
• Multimodality Imaging of Dementia: Clinical Importance and Role of Integrated Anatomic and Molecular Imaging.

  2020cites this paper
• Pharmacologic normalization of pathogenic dosage underlying genetic diseases: an overview of the literature and path forward.

  2019cites this paper
• Gantenerumab reduces amyloid-β plaques in patients with prodromal to moderate Alzheimer’s disease: a PET substudy interim analysis

  2019cites this paper
• Interactions between Curcumin Derivatives and Amyloid-β Fibrils: Insights from Molecular Dynamics Simulations

  2019cites this paper
• Potential Therapeutic Impacts of Curcumin Against Age-Related Impaired Cognition and Memory

  2019cites this paper
• Effect of N-Acetyl Cysteine on Intracerebroventricular Colchicine Induced Cognitive Deficits, Beta Amyloid Pathology, and Glial Cells

  2019cites this paper
• Conceptualization of computational modeling approaches and interpretation of the role of neuroimaging indices in pathomechanisms for pre-clinical detection of Alzheimer Disease

  2018cites this paper
• Impaired Cerebral Autoregulation-A Common Neurovascular Pathway in Diabetes may Play a Critical Role in Diabetes-Related Alzheimer’s Disease

  2017cites this paper
• Modeling Alzheimer’s and Other Age Related Human Diseases in Embryonic Systems

  2017cites this paper